Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

26-May-23 - 23-May-24
Buy Ratio:53%

Up

# Net Buyers:35
# Net Sellers:31

Previous 52 Weeks

27-May-22 - 25-May-23
Buy Ratio:38%
# Net Buyers:31
# Net Sellers:51
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Larimar Therapeutics, Inc.$38.00M$38.00M  
Dynavax Technologies Corp($21.58M)$22.46M  
Neurocrine Biosciences Inc$19.74M$19.20M  
Johnson & Johnson($6.84M)$17.05M  
Kalvista Pharmaceuticals, Inc.$12.70M$12.70M  
New Net Buyers
CompanyNet Buy AmountChange
Sarepta Therapeutics, Inc.$5.27M$5.28M  
Exelixis, Inc.$1.15M$4.73M  
Amicus Therapeutics, Inc.$79.75K$3.09M  
Regeneron Pharmaceuticals, Inc.$1.69M$1.75M  
Seagen Inc.$245.76K$1.29M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Immunitybio, Inc.--($56.63M)  
Biomarin Pharmaceutical Inc($18.94M)($16.52M)  
Chinook Therapeutics, Inc.--($7.98M)  
Blueprint Medicines Corp($5.58M)($5.58M)  
Incyte Corp--($4.84M)  
New Net Sellers
CompanyNet Buy AmountChange
Gilead Sciences, Inc.($890.90K)($2.07M)  
Aldeyra Therapeutics, Inc.($107.07K)($122.09K)  
Cidara Therapeutics, Inc.($35.32K)($87.17K)